| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| foreskin fibroblast (neonatal) | granulocyte-macrophage colony-stimulating factor receptor subunit alpha | biotech | NA | drugbank | Tendon structure[MeSHID:D013710] Joint Capsule[MeSHID:D017746] Injury wounds[MeSHID:D014947] Dermis[MeSHID:D020405] Bone Tissue[MeSHID:D001842] Foot[MeSHID:D005528] Muscle[MeSHID:D009132] Diabetic Foot[MeSHID:D017719] |
NA | approved | agonist |
| foreskin fibroblast (neonatal) | fibroblast growth factor 1 | biotech | NA | drugbank | Tendon structure[MeSHID:D013710] Joint Capsule[MeSHID:D017746] Injury wounds[MeSHID:D014947] Dermis[MeSHID:D020405] Bone Tissue[MeSHID:D001842] Foot[MeSHID:D005528] Muscle[MeSHID:D009132] Diabetic Foot[MeSHID:D017719] |
NA | approved | agonist |
| foreskin fibroblast (neonatal) | fibroblast growth factor receptor 2 | biotech | NA | drugbank | Tendon structure[MeSHID:D013710] Joint Capsule[MeSHID:D017746] Injury wounds[MeSHID:D014947] Dermis[MeSHID:D020405] Bone Tissue[MeSHID:D001842] Foot[MeSHID:D005528] Muscle[MeSHID:D009132] Diabetic Foot[MeSHID:D017719] |
NA | approved | agonist |
| foreskin fibroblast (neonatal) | vascular endothelial growth factor receptor 1 | biotech | NA | drugbank | Tendon structure[MeSHID:D013710] Joint Capsule[MeSHID:D017746] Injury wounds[MeSHID:D014947] Dermis[MeSHID:D020405] Bone Tissue[MeSHID:D001842] Foot[MeSHID:D005528] Muscle[MeSHID:D009132] Diabetic Foot[MeSHID:D017719] |
NA | approved | agonist |
| foreskin fibroblast (neonatal) | interferon gamma | biotech | NA | drugbank | Tendon structure[MeSHID:D013710] Joint Capsule[MeSHID:D017746] Injury wounds[MeSHID:D014947] Dermis[MeSHID:D020405] Bone Tissue[MeSHID:D001842] Foot[MeSHID:D005528] Muscle[MeSHID:D009132] Diabetic Foot[MeSHID:D017719] |
NA | approved | agonist |
| foreskin fibroblast (neonatal) | interleukin-1 receptor type 1 | biotech | NA | drugbank | Tendon structure[MeSHID:D013710] Joint Capsule[MeSHID:D017746] Injury wounds[MeSHID:D014947] Dermis[MeSHID:D020405] Bone Tissue[MeSHID:D001842] Foot[MeSHID:D005528] Muscle[MeSHID:D009132] Diabetic Foot[MeSHID:D017719] |
NA | approved | agonist |
| foreskin fibroblast (neonatal) | interleukin-6 | biotech | NA | drugbank | Tendon structure[MeSHID:D013710] Joint Capsule[MeSHID:D017746] Injury wounds[MeSHID:D014947] Dermis[MeSHID:D020405] Bone Tissue[MeSHID:D001842] Foot[MeSHID:D005528] Muscle[MeSHID:D009132] Diabetic Foot[MeSHID:D017719] |
NA | approved | agonist |
| foreskin fibroblast (neonatal) | platelet-derived growth factor receptor beta | biotech | NA | drugbank | Tendon structure[MeSHID:D013710] Joint Capsule[MeSHID:D017746] Injury wounds[MeSHID:D014947] Dermis[MeSHID:D020405] Bone Tissue[MeSHID:D001842] Foot[MeSHID:D005528] Muscle[MeSHID:D009132] Diabetic Foot[MeSHID:D017719] |
NA | approved | agonist |
| foreskin fibroblast (neonatal) | transforming growth factor beta-1 | biotech | NA | drugbank | Tendon structure[MeSHID:D013710] Joint Capsule[MeSHID:D017746] Injury wounds[MeSHID:D014947] Dermis[MeSHID:D020405] Bone Tissue[MeSHID:D001842] Foot[MeSHID:D005528] Muscle[MeSHID:D009132] Diabetic Foot[MeSHID:D017719] |
NA | approved | agonist |
| foreskin fibroblast (neonatal) | tgf-beta receptor type-2 | biotech | NA | drugbank | Tendon structure[MeSHID:D013710] Joint Capsule[MeSHID:D017746] Injury wounds[MeSHID:D014947] Dermis[MeSHID:D020405] Bone Tissue[MeSHID:D001842] Foot[MeSHID:D005528] Muscle[MeSHID:D009132] Diabetic Foot[MeSHID:D017719] |
NA | approved | agonist |
| foreskin fibroblast (neonatal) | tumor necrosis factor | biotech | NA | drugbank | Tendon structure[MeSHID:D013710] Joint Capsule[MeSHID:D017746] Injury wounds[MeSHID:D014947] Dermis[MeSHID:D020405] Bone Tissue[MeSHID:D001842] Foot[MeSHID:D005528] Muscle[MeSHID:D009132] Diabetic Foot[MeSHID:D017719] |
NA | approved | agonist |
| click here to return to the previous page | ||||||||